Enovis Net Profit Margin 2011-2025 | ENOV
Enovis net profit margin from 2011 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Enovis Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-06-30 | $2.19B | $-0.83B | -37.81% |
| 2025-03-31 | $2.15B | $-0.81B | -37.67% |
| 2024-12-31 | $2.11B | $-0.83B | -39.20% |
| 2024-09-30 | $2.00B | $-0.12B | -6.00% |
| 2024-06-30 | $1.91B | $-0.09B | -4.75% |
| 2024-03-31 | $1.82B | $-0.08B | -4.51% |
| 2023-12-31 | $1.71B | $-0.03B | -1.93% |
| 2023-09-30 | $1.66B | $-0.08B | -4.51% |
| 2023-06-30 | $1.63B | $-0.14B | -8.54% |
| 2023-03-31 | $1.59B | $-0.05B | -3.26% |
| 2022-12-31 | $1.56B | $-0.01B | -0.90% |
| 2022-09-30 | $0.99B | $0.02B | 2.34% |
| 2022-06-30 | $0.96B | $0.12B | 12.07% |
| 2022-03-31 | $0.92B | $0.07B | 7.38% |
| 2021-12-31 | $1.43B | $0.07B | 5.05% |
| 2021-09-30 | $0.47B | $0.11B | 22.62% |
| 2021-06-30 | $0.92B | $0.09B | 10.23% |
| 2021-03-31 | $1.18B | $0.06B | 4.82% |
| 2020-12-31 | $1.12B | $0.04B | 3.75% |
| 2020-09-30 | $3.13B | $-0.01B | -0.26% |
| 2020-06-30 | $3.17B | $-0.01B | -0.35% |
| 2020-03-31 | $3.46B | $-0.47B | -13.64% |
| 2019-12-31 | $3.33B | $-0.53B | -15.87% |
| 2019-09-30 | $2.67B | $-0.47B | -17.44% |
| 2019-06-30 | $2.34B | $-0.44B | -18.94% |
| 2019-03-31 | $2.00B | $0.06B | 3.16% |
| 2018-12-31 | $2.19B | $0.14B | 6.38% |
| 2018-09-30 | $1.48B | $0.11B | 7.24% |
| 2018-06-30 | $1.80B | $0.12B | 6.79% |
| 2018-03-31 | $2.09B | $0.14B | 6.57% |
| 2017-12-31 | $1.94B | $0.15B | 7.79% |
| 2017-09-30 | $3.01B | $0.18B | 5.84% |
| 2017-06-30 | $2.93B | $0.16B | 5.39% |
| 2017-03-31 | $3.04B | $0.15B | 4.77% |
| 2016-12-31 | $3.19B | $0.13B | 4.05% |
| 2016-09-30 | $3.13B | $0.14B | 4.31% |
| 2016-06-30 | $3.33B | $0.13B | 3.75% |
| 2016-03-31 | $3.40B | $0.14B | 4.06% |
| 2015-12-31 | $3.43B | $0.17B | 4.86% |
| 2015-09-30 | $4.11B | $0.20B | 4.94% |
| 2015-06-30 | $4.31B | $0.26B | 5.99% |
| 2015-03-31 | $4.48B | $0.40B | 8.86% |
| 2014-12-31 | $4.62B | $0.37B | 8.00% |
| 2014-09-30 | $4.59B | $0.33B | 7.08% |
| 2014-06-30 | $4.44B | $0.30B | 6.80% |
| 2014-03-31 | $4.31B | $0.16B | 3.78% |
| 2013-12-31 | $4.21B | $0.16B | 3.76% |
| 2013-09-30 | $4.06B | $0.14B | 3.40% |
| 2013-06-30 | $4.00B | $0.09B | 2.30% |
| 2013-03-31 | $3.97B | $0.05B | 1.16% |
| 2012-12-31 | $3.91B | $-0.08B | -2.12% |
| 2012-09-30 | $3.06B | $-0.11B | -3.72% |
| 2012-06-30 | $2.28B | $-0.11B | -5.00% |
| 2012-03-31 | $1.42B | $-0.11B | -7.81% |
| 2011-12-31 | $0.69B | $0.01B | 0.72% |
| 2011-09-30 | $0.68B | $0.03B | 4.39% |
| 2011-06-30 | $0.65B | $0.03B | 4.96% |
| 2011-03-31 | $0.58B | $0.02B | 4.13% |
| 2010-12-31 | $0.54B | $0.02B | 3.14% |
| 2010-09-30 | $0.51B | $0.02B | 2.96% |
| 2010-06-30 | $0.50B | $0.02B | 2.98% |
| 2010-03-31 | $0.51B | $0.02B | 3.34% |
| 2009-12-31 | $0.53B | $0.02B | 4.57% |
| 2009-09-30 | $0.55B | $0.03B | 5.06% |
| 2009-06-30 | $0.58B | $0.04B | 6.24% |
| 2009-03-31 | $0.61B | $0.00B | -0.49% |
| 2008-12-31 | $0.60B | $0.00B | -0.50% |
| 2008-09-30 | $0.59B | $-0.01B | -1.87% |
| 2008-06-30 | $0.56B | 0 | 0.00% |
| 2008-03-31 | $0.52B | $0.04B | 7.66% |
| 2007-12-31 | $0.51B | $0.04B | 7.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.787B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.674B | 59.39 |
| Tempus AI (TEM) | United States | $12.352B | 0.00 |
| Doximity (DOCS) | United States | $9.545B | 39.50 |
| Hims & Hers Health (HIMS) | United States | $8.883B | 72.26 |
| IRhythm Technologies (IRTC) | United States | $5.771B | 0.00 |
| Hinge Health (HNGE) | United States | $3.320B | 0.00 |
| Heartflow (HTFL) | United States | $2.981B | 0.00 |
| Privia Health (PRVA) | United States | $2.979B | 186.31 |
| Inspire Medical Systems (INSP) | United States | $2.642B | 43.71 |
| 10x Genomics (TXG) | United States | $2.078B | 0.00 |
| Omnicell (OMCL) | United States | $1.654B | 33.82 |
| Azenta (AZTA) | United States | $1.410B | 61.54 |
| Phreesia (PHR) | United States | $1.387B | 0.00 |
| Schrodinger (SDGR) | United States | $1.323B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.286B | 0.00 |
| Claritev (CTEV) | United States | $0.966B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.899B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.562B | 113.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Evolent Health (EVH) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.454B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.369B | 0.00 |
| Carlsmed (CARL) | United States | $0.328B | 0.00 |
| TruBridge (TBRG) | United States | $0.303B | 13.93 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.292B | 0.00 |
| CapsoVision (CV) | United States | $0.259B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.243B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.201B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.175B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| CareCloud (CCLD) | United States | $0.136B | 7.45 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| Pulmonx (LUNG) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |